Interleukin-2, killer cells and cancer therapy: an overview.
作者信息
Parkinson D R, Lotzová E
机构信息
Department of Clinical Immunology and Biological Therapy, University of Texas, M.D. Anderson Cancer Center, Houston.
出版信息
Nat Immun Cell Growth Regul. 1990;9(4):237-41.
PMID:2215512
Abstract
摘要
相似文献
1
Interleukin-2, killer cells and cancer therapy: an overview.
Nat Immun Cell Growth Regul. 1990;9(4):237-41.
2
The cellular and molecular basis of natural antitumor immunity in renal cell carcinoma patients.肾细胞癌患者天然抗肿瘤免疫的细胞和分子基础。
Urologe A. 2004 Sep;43 Suppl 3:S133-5. doi: 10.1007/s00120-004-0601-y.
3
4
Melanoma and immunity.黑色素瘤与免疫
Immunol Ser. 1989;46:769-87.
5
IL-2 therapy proves durable in renal cell melanoma patients.
Oncology (Williston Park). 1991 Sep;5(9):71.
6
7
The role of interleukin-2 in the biotherapy of cancer.白细胞介素-2在癌症生物治疗中的作用。
Oncol Nurs Forum. 1989 Nov-Dec;16(6 Suppl):16-20.
8
9
Lymphocyte therapy of renal cell carcinoma.肾细胞癌的淋巴细胞疗法。
Expert Rev Anticancer Ther. 2005 Dec;5(6):1041-51. doi: 10.1586/14737140.5.6.1041.
10
Lessons from the clinical trials of interleukin-2.白细胞介素-2临床试验的经验教训。
Nat Immun Cell Growth Regul. 1990;9(4):242-52.
引用本文的文献
1
ToxiM: A Toxicity Prediction Tool for Small Molecules Developed Using Machine Learning and Chemoinformatics Approaches.ToxiM：一种使用机器学习和化学信息学方法开发的小分子毒性预测工具。
Front Pharmacol. 2017 Nov 30;8:880. doi: 10.3389/fphar.2017.00880. eCollection 2017.
Zotero 插件